Cycloplatam

Drug Profile

Cycloplatam

Latest Information Update: 07 Nov 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator N. S. Kurnakov Institute of General and Inorganic Chemistry
  • Developer N. S. Kurnakov Institute of General and Inorganic Chemistry; Nonindustrial source
  • Class Antineoplastics; Platinum complexes; Small molecules
  • Mechanism of Action Protein kinase C inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer; Solid tumours

Most Recent Events

  • 28 Nov 2000 No-Development-Reported for Solid tumours in Russia (Unknown route)
  • 09 May 1995 Phase-II clinical trials for Solid tumours in Russia (Unknown route)
  • 04 May 1995 Preclinical development for Cancer in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top